Alpha 2.0
Login Register
» Authors » Kaya Doyeux

Kaya Doyeux

Explore the profile of Kaya Doyeux including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 122
Followers 0
Related Specialties
Radiology
Nuclear Medicine
Oncology
Top 10 Co-Authors
Isabelle Gardin
Pierre Vera
Bernard DuBray
Agathe Edet-Sanson
Sebastien Hapdey
Florent Martinetti
Christine Haie-Meder
Claire Petit
Pierre Maroun
Sebastien Thureau
Published In
J Nucl Med
Brachytherapy
Acta Oncol
Radiother Oncol
Nucl Med Commun
Affiliations
Soon will be listed here.
Recent Articles
1.
MRI-guided brachytherapy in locally advanced cervical cancer: Small bowel [Formula: see text] and [Formula: see text] are not predictive of late morbidity
Petit C, Dumas I, Chargari C, Martinetti F, Maroun P, Doyeux K, et al.
Brachytherapy . 2016 May; 15(4):463-470. PMID: 27180130
Purpose: To establish dose-volume effect correlations for late small bowel (SB) toxicities in patients treated for locally advanced cervical cancer with concomitant chemoradiation followed by pulsed-dose rate MRI-guided adaptive brachytherapy....
2.
Vaginal dose assessment in image-guided brachytherapy for cervical cancer: Can we really rely on dose-point evaluation?
Limkin E, Dumas I, Rivin Del Campo E, Chargari C, Maroun P, Annede P, et al.
Brachytherapy . 2016 Jan; 15(2):169-76. PMID: 26778755
Purpose: Although dose-volume parameters in image-guided brachytherapy have become a standard, the use of posterior-inferior border of the pubic symphysis (PIBS) points has been recently proposed in the reporting of...
3.
FDG-PET/CT during concomitant chemo radiotherapy for esophageal cancer: Reducing target volumes to deliver higher radiotherapy doses
Nkhali L, Thureau S, Edet-Sanson A, Doyeux K, Benyoucef A, Gardin I, et al.
Acta Oncol . 2014 Nov; 54(6):909-15. PMID: 25417733
Background: A planning study investigated whether reduced target volumes defined on FDG-PET/CT during radiotherapy allow total dose escalation without compromising normal tissue tolerance in patients with esophageal cancer. Material And...
4.
Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3'-deoxy-3'-18F-fluorothymidine PET images in lung cancer
Thureau S, Chaumet-Riffaud P, Modzelewski R, Fernandez P, Tessonnier L, Vervueren L, et al.
J Nucl Med . 2013 Aug; 54(9):1543-50. PMID: 23918733
Unlabelled: As the preparation phase of a multicenter clinical trial using (18)F-fluoro-2-deoxy-d-glucose ((18)F-FDG), (18)F-fluoromisonidazole ((18)F-FMISO), and 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) in non-small cell lung cancer (NSCLC) patients, we investigated whether 18 nuclear...
5.
Reproducibility of the adaptive thresholding calibration procedure for the delineation of 18F-FDG-PET-positive lesions
Doyeux K, Vauclin S, Hapdey S, Daouk J, Edet-Sanson A, Vera P, et al.
Nucl Med Commun . 2013 Mar; 34(5):432-8. PMID: 23478589
Objective: The aim of the study was to evaluate the robustness of the calibration procedure against the counting statistics and lesion volumes when using an adaptive thresholding method for the...
6.
Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC)
Edet-Sanson A, DuBray B, Doyeux K, Back A, Hapdey S, Modzelewski R, et al.
Radiother Oncol . 2011 Sep; 102(2):251-7. PMID: 21885145
Objectives: The objectives were (i) to confirm that diagnostic FDG-PET images could be obtained during thoracic radiotherapy, (ii) to verify that significant changes in FDG uptake or volume could be...
7.
Comparative assessment of methods for estimating tumor volume and standardized uptake value in (18)F-FDG PET
Tylski P, Stute S, Grotus N, Doyeux K, Hapdey S, Gardin I, et al.
J Nucl Med . 2010 Jan; 51(2):268-76. PMID: 20080896
Unlabelled: In (18)F-FDG PET, tumors are often characterized by their metabolically active volume and standardized uptake value (SUV). However, many approaches have been proposed to estimate tumor volume and SUV...